Bio Health sector innovations targeting oncology. Novel therapies, platforms & technologies.
Partnering, Licensing & Business Development, what industry is looking for.
VC & Investment, who is funding what.
Engage with key partners, globally.
From the lab & the clinic, a selection of world-class innovations, technology transfer assets and leading companies - selected by industry & investment KOLs, not by registration fee.
REGISTRATION IS FREE FOR INNOVATION STAKEHOLDERS
Key themes & discussion topics include:
Industry collaborations - what pharma & industry want
Health System innovation needs
Government, grant funding & innovation programs
Venture Capital & investment
Roundtables & workshops
Oncology innovations from translational research to the clinic.
Keynotes from leading institutes, Investor panels with active oncology investors, networking & engagement with innovation stakeholders from research, technology transfer & licensing, startup & growth companies, industry & investors worldwide.
SPEAKERS
Michael Salgaller
Supervisor, Invention Development and Marketing Unit (IDMU),Technology Transfer Center, National Cancer Institute
Jeroen Bakker
Principal,
Novo Seeds / Novo Holdings
Melissa McCracken
Principal,
Nextech Invest
Alice Lin Pomponio
Managing Director
BrightEdge Philanthropic Impact Fund,
American Cancer Society
Tony Hickson
Chief Business Officer
Cancer Research UK
Kevin Noonan
Partner, Chair of the Biotechnology & Pharmaceuticals Practice Group, MBHB LLP
Matthew Miessau
Associate,
Epidarex Capital
Prof. Andrew Scott
Research Translation & Commercialisation Lead, Victorian Comprehensive Cancer Centre (VCCC)
Peter Neubeck
Partner,
Kurma Partners
Alejo Chorny
Operating Partner,
Advent France Biotechnology
Youssef Bennani
Managing Partner
CTI Life Sciences Fund
AGENDA
July 12
10:00 EDT
-
Welcome & Opening Remarks
-
Christian J. Suojanen - CEO, Broadreach Global
-
10:05 EDT
-
Addressing the Grand Challenges in Cancer Research & Innovation
-
Tony Hickson, Chief Business Officer, Cancer Research UK
-
10:45 EDT
-
ViroStatics - Company Presentation
-
Franco Lori, Chief Executive Officer
-
July 13
10:00 EDT
-
Welcome & Opening
10:15 EDT
-
Partnering with the National Cancer Institute
-
Michael Salgaller, Supervisor, Invention Development and Marketing Unit (IDMU),Technology Transfer Center, National Institutes of Health / National Cancer Institute
-
10:45 EDT
-
Investor Session I - What are active oncology focused investors looking for? What technologies, approaches & criteria will attract investments?
-
Jeroen Bakker, Principal, Novo Sooeds / Novo Holdings
-
Peter Neubeck, Partner, Kurma Partners
-
Alejo Chorny, Operating Partner, Advent France Biotechnology
-
Alice Lin Pomponio, Managing Director, BrightEdge Impact Fund, American Cancer Society
-
11:45 EDT
-
Deka Biosciences - Company Presentation
-
Pavel Khrimian, Chief Business Officer
-
July 14
10:00 EDT
-
Opportunities in Research Translation in Oncology.
-
Professor Andrew Scott, Research Translation & Commercialisation Lead, Victorian Comprehensive Cancer Centre (VCCC)
-
10:45 EDT
-
Investor Session II - Funding & building companies to transform cancer treatment
-
Melissa McCracken, Principal, Nextech Invest
-
Matthew Miessau, Associate, Epidarex Capital
-
Youssef Bennani, Managing Partner, CTI Life Sciences Fund
-
11:30 EDT
-
Protecting Oncology IP in the US - Developments & Strategies
-
Kevin Noonan, Partner, Head of the Biotechnology & Pharmaceutical Practice Group, MBHB LLP
-
July 15
10:00 EDT
-
Roundtable Discussion Panel
10:45 EDT
-
Ability Pharma - Company Presentation
-
Carles Domenech, Executive Chairman & Chief Scientific Officer
-
11:10 EDT
-
Scenic Biotech - Company Presentation
-
Sebastian Nijman & Chief Scientific Officer
-
11:10 EDT
-
ImCare Biotech - Company Presentation
-
Mina Soryal, Director, Commercial Strategy & Corporate Development
-